These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35426772)
1. Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice. Gugala E; Briggs O; Moczygemba LR; Brown CM; Hill LG Subst Abus; 2022; 43(1):972-987. PubMed ID: 35426772 [No Abstract] [Full Text] [Related]
2. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia. Uzwiak BA; Hudgins A; Pizzicato LN Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098 [TBL] [Abstract][Full Text] [Related]
4. Incoming medical students' knowledge of and attitudes toward people with substance use disorders: Implications for curricular training. Moses TE; Chammaa M; Ramos R; Waineo E; Greenwald MK Subst Abus; 2021; 42(4):692-698. PubMed ID: 33166242 [No Abstract] [Full Text] [Related]
5. A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Grella CE; Ostlie E; Scott CK; Dennis ML; Carnevale J; Watson DP Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):19. PubMed ID: 33618744 [TBL] [Abstract][Full Text] [Related]
6. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter. Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641 [No Abstract] [Full Text] [Related]
7. Changes in social work students' attitudes and knowledge following opioid overdose prevention training. Halmo RS; Sellers CM; Collin CR; Chinamasa G; Putney JM Subst Abus; 2022; 43(1):289-293. PubMed ID: 34214409 [No Abstract] [Full Text] [Related]
8. Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment. Kozak Z; Ciccarone D; Thrul J; Cole TO; Pappas AL; Greenblatt AD; Welsh C; Yoon M; Gann D; Artigiani EE; Wish ED; Belcher AM Harm Reduct J; 2023 Feb; 20(1):17. PubMed ID: 36788601 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of opioid overdose prevention and response training on medical student knowledge and attitudes toward opioid overdose: A pilot study. Moses TEH; Chou JS; Moreno JL; Lundahl LH; Waineo E; Greenwald MK Addict Behav; 2022 Mar; 126():107172. PubMed ID: 34774365 [TBL] [Abstract][Full Text] [Related]
11. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location. Kohan LR; Elmofty D; Pena I; Liao C J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425 [TBL] [Abstract][Full Text] [Related]
12. 'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone. Filteau MR; Green B; Kim F; McBride KA Harm Reduct J; 2022 Oct; 19(1):111. PubMed ID: 36192736 [TBL] [Abstract][Full Text] [Related]
13. Opioid Overdose Harm Prevention: The Role of the Nurse in Patient Education. Gilles S Nurs Clin North Am; 2022 Sep; 57(3):477-488. PubMed ID: 35985734 [TBL] [Abstract][Full Text] [Related]
14. Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder. Osibanjo O; Reinhardt R; Clemans S; Andoniadis S; Carson P; Benkstein K J Am Pharm Assoc (2003); 2023; 63(1):396-402. PubMed ID: 36564331 [TBL] [Abstract][Full Text] [Related]
15. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose. Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682 [TBL] [Abstract][Full Text] [Related]
16. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community. Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898 [TBL] [Abstract][Full Text] [Related]
17. Dispensing a Naloxone Kit at Hospital Discharge: A Retrospective QI Project. Train MK; Patel N; Thapa K; Pasho M; Acquisto NM Am J Nurs; 2020 Dec; 120(12):48-52. PubMed ID: 33214374 [TBL] [Abstract][Full Text] [Related]
18. A Comparative Analysis of Online Versus in-Person Opioid Overdose Awareness and Reversal Training for First-Year Medical Students. Goss NC; Haslund-Gourley B; Meredith DM; Friedman AV; Kumar VK; Samson KR; Fitzgerald EJ; Damaraju S; Verdone JE; Edelman J; Anlage TJ; Albrecht DG; Gorisek SR; Carnevale A; Gadegbeku AB Subst Use Misuse; 2021; 56(13):1962-1971. PubMed ID: 34355637 [TBL] [Abstract][Full Text] [Related]
19. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction. DiPaula BA; Cooke CE; Boyle CJ; Love RC J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080 [TBL] [Abstract][Full Text] [Related]
20. Economic Evaluation in Opioid Modeling: Systematic Review. Beaulieu E; DiGennaro C; Stringfellow E; Connolly A; Hamilton A; Hyder A; Cerdá M; Keyes KM; Jalali MS Value Health; 2021 Feb; 24(2):158-173. PubMed ID: 33518022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]